Regeneron Pharmaceuticals Valuation
| REGN Stock | USD 900.16 3.34 0.37% |
At this time, the company appears to be fairly valued. Regeneron Pharmaceuticals holds a recent Real Value of $917.14 per share. The prevailing price of the company is $900.16. Our model determines the value of Regeneron Pharmaceuticals from analyzing the company fundamentals such as Shares Outstanding of 107.94 M, return on equity of 0.16, and Operating Margin of 0.29 % as well as examining its technical indicators and probability of bankruptcy. In general, most investors support obtaining undervalued entities and abandoning overvalued entities since, at some point, asset prices and their ongoing real values will merge together. Key fundamental drivers impacting Regeneron Pharmaceuticals' valuation include:
Price Book 3.8232 | Enterprise Value 88.3 B | Enterprise Value Ebitda 19.4231 | Price Sales 7.5703 | Forward PE 20.1207 |
Fairly Valued
Today
Please note that Regeneron Pharmaceuticals' price fluctuation is very steady at this time. Calculation of the real value of Regeneron Pharmaceuticals is based on 3 months time horizon. Increasing Regeneron Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Regeneron Pharmaceuticals is useful when determining the fair value of the Regeneron stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Regeneron Pharmaceuticals. Since Regeneron Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Regeneron Stock. However, Regeneron Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 900.16 | Real 917.14 | Target 912.52 | Hype 899.54 |
The real value of Regeneron Stock, also known as its intrinsic value, is the underlying worth of Regeneron Pharmaceuticals Company, which is reflected in its stock price. It is based on Regeneron Pharmaceuticals' financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Regeneron Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Regeneron Pharmaceuticals' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Regeneron Pharmaceuticals helps investors to forecast how Regeneron stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Regeneron Pharmaceuticals more accurately as focusing exclusively on Regeneron Pharmaceuticals' fundamentals will not take into account other important factors: Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Regeneron Pharmaceuticals' intrinsic value based on its ongoing forecasts of Regeneron Pharmaceuticals' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Regeneron Pharmaceuticals' closest peers. When choosing an evaluation method for Regeneron Pharmaceuticals, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.
Regeneron Pharmaceuticals Investments |
|
Regeneron Valuation Trend
Knowing Regeneron Pharmaceuticals' actual value is paramount for traders to make sound investment determinations. Regeneron Pharmaceuticals' real value is not only important for the investor to make better decisions but also for a more accurate overall view of Regeneron Pharmaceuticals' financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Regeneron Pharmaceuticals' enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.
Regeneron Market Cap
Regeneron Pharmaceuticals is rated second in market capitalization category among related companies. Market capitalization of Health Care industry is at this time estimated at about 793.88 Billion. Regeneron Pharmaceuticals retains roughly 98.44 Billion in market capitalization claiming about 12% of equities under Health Care industry.Regeneron Pharmaceuticals Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Regeneron Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Regeneron Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Regeneron Pharmaceuticals competition to find correlations between indicators driving Regeneron Pharmaceuticals's intrinsic value. More Info.Regeneron Pharmaceuticals is rated below average in price to earning category among related companies. It is rated below average in price to book category among related companies fabricating about 0.25 of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for Regeneron Pharmaceuticals is roughly 4.06 . As of the 23rd of April 2024, Price To Book Ratio is likely to grow to 5.22. Comparative valuation analysis is a catch-all model that can be used if you cannot value Regeneron Pharmaceuticals by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Regeneron Pharmaceuticals' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Regeneron Pharmaceuticals' earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Regeneron Pharmaceuticals' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Regeneron Pharmaceuticals and how it compares across the competition.
About Regeneron Pharmaceuticals Valuation
The stock valuation mechanism determines the current worth of Regeneron Pharmaceuticals on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Regeneron Pharmaceuticals. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Regeneron Pharmaceuticals based exclusively on its fundamental and basic technical indicators. By analyzing Regeneron Pharmaceuticals's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Regeneron Pharmaceuticals's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Regeneron Pharmaceuticals. We calculate exposure to Regeneron Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Regeneron Pharmaceuticals's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 12.2 B | 12.8 B | |
| Pretax Profit Margin | 0.32 | 0.34 | |
| Operating Profit Margin | 0.31 | 0.32 | |
| Net Profit Margin | 0.30 | 0.32 | |
| Gross Profit Margin | 0.86 | 0.64 |
8 Steps to conduct Regeneron Pharmaceuticals' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Regeneron Pharmaceuticals' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Regeneron Pharmaceuticals' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Regeneron Pharmaceuticals' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Regeneron Pharmaceuticals' revenue streams: Identify Regeneron Pharmaceuticals' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Regeneron Pharmaceuticals' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Regeneron Pharmaceuticals' growth potential: Evaluate Regeneron Pharmaceuticals' management, business model, and growth potential.
- Determine Regeneron Pharmaceuticals' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Regeneron Pharmaceuticals' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Regeneron Pharmaceuticals Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Regeneron Pharmaceuticals does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 113.7 M | |
| Quarterly Earnings Growth Y O Y | -0.029 | |
| Forward Price Earnings | 20.1207 |
Regeneron Pharmaceuticals Current Valuation Indicators
Valuation refers to the process of determining the present value of Regeneron Pharmaceuticals and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Regeneron we look at many different elements of the entity such as Regeneron's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Regeneron Pharmaceuticals' valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Regeneron Pharmaceuticals' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Regeneron Pharmaceuticals, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Regeneron Pharmaceuticals' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Regeneron Pharmaceuticals' worth.When determining whether Regeneron Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Regeneron Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Regeneron Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Regeneron Pharmaceuticals Stock: Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Regeneron Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. To learn how to invest in Regeneron Stock, please use our How to Invest in Regeneron Pharmaceuticals guide.Note that the Regeneron Pharmaceuticals information on this page should be used as a complementary analysis to other Regeneron Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Complementary Tools for Regeneron Stock analysis
When running Regeneron Pharmaceuticals' price analysis, check to measure Regeneron Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regeneron Pharmaceuticals is operating at the current time. Most of Regeneron Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Regeneron Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regeneron Pharmaceuticals' price. Additionally, you may evaluate how the addition of Regeneron Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |
Is Regeneron Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Regeneron Pharmaceuticals. If investors know Regeneron will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Regeneron Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.03) | Earnings Share 34.8 | Revenue Per Share 122.935 | Quarterly Revenue Growth 0.006 | Return On Assets 0.0849 |
The market value of Regeneron Pharmaceuticals is measured differently than its book value, which is the value of Regeneron that is recorded on the company's balance sheet. Investors also form their own opinion of Regeneron Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Regeneron Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Regeneron Pharmaceuticals' market value can be influenced by many factors that don't directly affect Regeneron Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Regeneron Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Regeneron Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Regeneron Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.